USES OF ANTAGONISTS OF HYALURONAN SIGNALING
France
13790928.9
Filed on 2013-03-08
13790928.9
Filed on 2013-03-08
USES OF ANTAGONISTS OF HYALURONAN SIGNALING
Germany
13790928.9
Filed on 2013-03-08
13790928.9
Filed on 2013-03-08
USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS
Patent Cooperation Treaty
PCT/US2019/29801
Filed on 2019-04-30
PCT/US2019/29801
Filed on 2019-04-30
Methods And Composition For Treating Nephropathy
US Application 15/739,718
Filed on 2017-12-23
Filed on 2017-12-23
Novel Strategy For Inhibiting HIV-1 Reverse Transcriptase
Patent Cooperation Treaty
PCT/US2018/045874
Filed on 2018-08-08
PCT/US2018/045874
Filed on 2018-08-08
Methods for Improving Drug Delivery Across the Blood-Brain Barrier
Patent Cooperation Treaty
PCT/US2017/031206
Filed on 2017-05-05
PCT/US2017/031206
Filed on 2017-05-05
Methods And Composition For Treating Nephropathy
Patent Cooperation Treaty
PCT/US16/035548
Filed on 2016-06-02
PCT/US16/035548
Filed on 2016-06-02
USES OF ANTAGONISTS OF HYALURONAN SIGNALING
US Patent 9,717,752
Filed on 2014-11-04
Filed on 2014-11-04
USES OF ANTAGONISTS OF HYALURONAN SIGNALING
European Patent
13790928.9
Filed on 2013-03-08
13790928.9
Filed on 2013-03-08
USES OF ANTAGONISTS OF HYALURONAN SIGNALING
Canada
2872569
Filed on 2013-03-08
2872569
Filed on 2013-03-08